eBioMedicine, 2022 · DOI: https://doi.org/10.1016/j.ebiom.2022.103845 · Published: February 1, 2022
Lumbar intervertebral disc (IVD) herniations cause significant disability. Current surgical treatments like discectomy, while relieving symptoms, can cause further disc degeneration due to the IVD's limited self-repair ability. This study explores using ultra-purified, GMP-compliant human bone marrow mesenchymal stem cells (RECs) combined with a bioresorbable gel to regenerate IVDs after discectomy. The study found that RECs combined with the gel enhanced IVD regeneration in sheep with severe IVD degeneration, demonstrating translational potential for treating herniations in degenerative human IVDs.
The study suggests a potential new treatment approach for intervertebral disc herniations using a combination of stem cells and a bioresorbable gel.
The combination therapy enhances IVD regeneration more effectively than the gel alone, offering a potential solution for preventing further disc degeneration after discectomy.
The study indicates that the use of ultra-purified stem cells in combination with the gel does not result in neoplastic changes, supporting its safety as a therapeutic intervention.